U.S. Synthetic Biology Market Size & Outlook, 2023-2030
U.S. synthetic biology market, 2018-2030 (US$M)
Related Markets
U.S. synthetic biology market highlights
- The U.S. synthetic biology market generated a revenue of USD 4,808.5 million in 2023 and is expected to reach USD 20,080.0 million by 2030.
- The U.S. market is expected to grow at a CAGR of 22.7% from 2024 to 2030.
- In terms of segment, pcr technology was the largest revenue generating technology in 2023.
- NGS Technology is the most lucrative technology segment registering the fastest growth during the forecast period.
Synthetic biology market data book summary
| Market revenue in 2023 | USD 4,808.5 million |
| Market revenue in 2030 | USD 20,080.0 million |
| Growth rate | 22.7% (CAGR from 2023 to 2030) |
| Largest segment | Pcr technology |
| Fastest growing segment | NGS Technology |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | NGS Technology, PCR Technology, Genome Editing Technology, Bioprocessing Technology, Other Technologies |
| Key market players worldwide | Basf SE, Codexis Inc, Illumina Inc, Merck KGaA, New England Biolabs, Eurofins Scientific SE, Novozymes, DNAstar, Synthego, Thermo Fisher Scientific Inc |
Other key industry trends
- In terms of revenue, U.S. accounted for 34.0% of the global synthetic biology market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. synthetic biology market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 4,768.7 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Synthetic Biology Market Scope
Synthetic Biology Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. synthetic biology market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to synthetic biology market will help companies and investors design strategic landscapes.
Pcr technology was the largest segment with a revenue share of 27.64% in 2023. Horizon Databook has segmented the U.S. synthetic biology market based on ngs technology, pcr technology, genome editing technology, bioprocessing technology, other technologies covering the revenue growth of each sub-segment from 2018 to 2030.
The U.S. is leading synthetic biology as well as biomedical &biotechnology research space. The U.S. synthetic biology market is majorly driven by high investment in the private sector. These investments are expected to lead to introduction of at least new 100 products in the U.S. market in the coming years.
The company will focus on expansion of research & development activities through this investment. In addition, in November 2020, Sumitomo Chemical launched SynBio Hub, a new organization which will focus on accelerating next-generation synthetic biology business in the U.S.
Reasons to subscribe to U.S. synthetic biology market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. synthetic biology market databook
-
Our clientele includes a mix of synthetic biology market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. synthetic biology market , including forecasts for subscribers. This country databook contains high-level insights into U.S. synthetic biology market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. synthetic biology market size, by technology, 2018-2030 (US$M)
U.S. Synthetic Biology Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
